Inhibikase Therapeutics Inc. (IKT)

Market Open

1 Sep, 19:46

NASDAQ (CM)

$

2. 40

+0.08

+3.6797%

305M Market Cap

- P/E Ratio

- Div Yield

355,547 Volume

-1.77 Eps

$ 2.31

Previous Close

Investors:

Add Transaction

Day Range

2.27 2.4

Year Range

1.33 2.54

Want to track IKT and more in your Portfolio? 🎯

Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Get Started For Free

Inhibikase Therapeutics Inc. Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
Curtis Ellergodt Rothschild Investment LLC	28	$47	$68.32	$21.32	45.36%
BG Bart Gancher Intech Investment Management LLC	28,626	$55,512.38	$70,706.22	$15,193.84	27.37%
Joseph Castro Nuveen LLC	425,492	$723,399.31	$1.04M	$319,056.09	44.11%
Bobby Adusumilli SJS Investment Consulting Inc.	9	$15.12	$19.62	$4.5	29.76%
Hui Fai Tam Caitong International Asset Management Co. Ltd.	148	$248.37	$361.12	$112.75	45.4%
Kevin Kroskey True Wealth Design LLC	43	$73	$93.74	$20.74	28.41%
Christopher C. Powers Farther Finance Advisors, LLC	370	$678.79	$806.6	$127.81	18.83%
Raymond Debbane Siren, L.L.C.	5.85M	$11.99M	$14.04M	$2.05M	17.07%
RJ Rebecca Judd Pathstone Holdings, LLC	510,596	$954,814.52	$1.23M	$270,615.88	28.34%
Ashley Meredith Abel Hall, LLC	46,352	$83,911.43	$101,047.36	$17,135.93	20.42%
Mark Schafer Police & Firemen's Retirement System of New Jersey	41,594	$79,191.72	$90,674.92	$11,483.2	14.5%
SummitTX Capital LP SummitTX Capital LP	1.78M	$3.04M	$4.29M	$1.25M	41.16%
Kennondale Capital Management LLC Kennondale Capital Management LLC	565,983	$1.06M	$1.39M	$328,270.14	31.02%

1

Blog Affiliate Program About Terms Privacy Help Contact Us

2026 © Marketlog. All Rights Reserved.